insights_auto
Nega 000739 tushdi 7,69%?
Batafsil oʻrganishchevron_right
000739:SHE
Apeloa Pharmaceutical Co Ltd
21,62Â CNÂ¥
arrow_downward
-7,69%(-1,80) 1K
19-okt, 15:04:21 (GMT+8) · CNY
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto000739 tikeri uchun statistika yaratilmoqda...
Ochish
23,02Â CNÂ¥
Yuqori
23,57Â CNÂ¥
Past
21,08Â CNÂ¥
Bozor kapitali
27,13Â mlrd
Oʻrtacha hajm
16,57Â mln
Hajmi
35,80Â mln
Dividend
1,74%
Choraklik dividendlar
0,09Â CNÂ¥
Eks-dividend sanasi
8-okt, 2026
P/E koeffitsiyenti
29,34
52 haftalik eng yuqori
28,50Â CNÂ¥
52 haftalik eng past
14,89Â CNÂ¥
Aksiya boʻyicha daromad
0,74Â CNÂ¥
Muomaladagi aksiyalar
1,16Â mlrd
Xodimlar soni
7Â ming
Ochish
23,02Â CNÂ¥
Yuqori
23,57Â CNÂ¥
Past
21,08Â CNÂ¥
Bozor kapitali
27,13Â mlrd
Oʻrtacha hajm
16,57Â mln
Hajmi
35,80Â mln
Dividend
1,74%
Choraklik dividendlar
0,09Â CNÂ¥
Eks-dividend sanasi
8-okt, 2026
P/E koeffitsiyenti
29,34
52 haftalik eng yuqori
28,50Â CNÂ¥
52 haftalik eng past
14,89Â CNÂ¥
Aksiya boʻyicha daromad
0,74Â CNÂ¥
Muomaladagi aksiyalar
1,16Â mlrd
Xodimlar soni
7Â ming
Aloqador aksiyalar
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ChartMill
·
43 daqiqa oldin
Microsoft (NASDAQ:MSFT): Dividend Quality and Safety Over Yield for Income Investors
Inc.com
·
36 daqiqa oldin
October’s Reputation for Historic Market Crashes Doesn’t Match Its Track Record
Yahoo Finance
·
1 soat oldin
Why Are Nasdaq Futures Soaring Premarket? NBIS, MU, TSLA, SPCX, ASTS, SLS Stocks In Focus
Bloomberg.com
·
11 soat oldin
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profil
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Apeloa Pharmaceutical Co Ltd haqida